You are here

Disease

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study

 

..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

California and Oregon ease CDC guidance, letting students and workers with asymptomatic COVID avoid isolation.

New York Times

Oregon and California, among the most cautious of states early in the pandemic, have surprised health officials elsewhere by breaking with Centers for Disease Control and Prevention guidelines and telling infected workers and schoolchildren that as long as they have no symptoms, they are generally free to go about their lives.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. Flu activity ticked down last week, but respiratory virus season is far from over

Flu activity ticked down last week, but respiratory virus season is far from over in the US

The United States started the new year awash in respiratory illness, with high levels of flu, Covid-19 and RSV across most of the country. The latest data from the US Centers for Disease Control and Prevention notes that some measures of flu activity dipped in early January, but the single week of decrease is not a trend – and experts warn that more increases are likely to come.

In the latest update this week, and consistently through the season, the agency’s Center for Forecasting and Outbreak Analytics has suggested that this respiratory disease season will probably result in a similar number of hospitalizations as last season. And while current hospital capacity is considered stable overall, the CDC says that hospitals in some parts of the country have reported strains on their resources due, in part, to increases in respiratory illness.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Long Covid: Change in a handful of blood proteins may pave way to tests and treatment --study

https://www.nbcnews.com/health/health-news/long-covid-cause-study-immune-system-complement-response-rcna134530

Scientists have identified a persistent change in a handful of blood proteins in people with long Covid that indicates that an important part of their immune system remains on high alert for months after an acute infection.

The findings, published Thursday in the journal Science, could help explain what causes the persistent fatigue, brain fog and other debilitating symptoms of long Covid, as well as pave the way for diagnostic tests and potentially, a long-awaited treatment, experts say. 

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New British study on How Long Does It Take to Get COVID-19

The length of time you spend around a person with COVID-19 seems to heavily influence your likelihood of getting sick, according to a recent Nature study that has been peer-reviewed but not fully edited. Most exposures that result in transmission last at least an hour, if not much longer, the researchers say.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Congressional health care legislation negotiations are still a struggle

...

As Congress hurtles toward another government funding deadline, conversations between the House and Senate over a package to fund important health programs and other add-ons providers want haven’t reached a conclusion

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Disease
howdy folks